R

Active Director Director DIN 10477580
DIN 10477580 First appointment Jan 2024 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Ranjitha

Data last updated:

Ranjitha is a Director at Infinets Biotech Private Limited (since 2024). The company operates in Trading. Infinets Biotech Private Limited reported revenue of ₹2.62 Cr (FY 2024).

DIN 10477580
Primary Designation Director
Industry Trading
First Appointment 24 Jan 2024
Oldest Company Age 5 yrs
Largest company Infinets Biotech Private Limited · ₹2.62 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Infinets Biotech Private Limited U51909TN2021PTC146447
Director24 Jan 20242021₹2.62 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Infinets Biotech Private Limited
Premium access

Shareholding and investment profile for Ranjitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjitha

Ranjitha currently holds 1 directorship: Infinets Biotech Private Limited (Director, since 24 Jan 2024, revenue ₹2.62 Cr (FY 2024)).

Ranjitha was first appointed on 24 Jan 2024 as Director at Infinets Biotech Private Limited.

The current boards of Ranjitha's companies include Srinivasan Kamakshi (Infinets Biotech Private Limited), Subas Chandra Bose Muraleeswara Saravanan (Infinets Biotech Private Limited), Sundaramoorthi Karthikeyan (Infinets Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available